Avian Coccidiosis in Broilers: Eimeria Species Identification and Anticoccidial Resistance

Introduction

Avian coccidiosis is a parasitic enteric disease of poultry caused by apicomplexan protozoa of the genus Eimeria. In broiler chickens, the disease imposes substantial economic losses through reduced feed conversion, impaired weight gain, increased mortality, and the costs associated with prophylactic and therapeutic interventions [1, 2]. Seven species of Eimeria are recognized as pathogenic in chickens: E. acervulina, E. brunetti, E. maxima, E. mitis, E. necatrix, E. praecox, and E. tenella [3]. Each species exhibits a distinct predilection for specific regions of the intestinal tract, and the severity of pathology correlates with the site of infection and the parasite burden [4].

The control of coccidiosis in commercial broiler operations has historically relied on the routine inclusion of anticoccidial drugs in feed. However, the widespread and prolonged use of these compounds has selected for resistant parasite populations, compromising the efficacy of many chemical agents [5, 6]. Accurate species identification is a prerequisite for targeted control strategies, including the selection of appropriate anticoccidials and the deployment of live or recombinant vaccines [7]. This article provides a detailed examination of the methods used for Eimeria species identification in broilers, including lesion scoring, oocyst morphology, and molecular typing, and reviews the current understanding of anticoccidial resistance mechanisms and monitoring approaches.

Pathophysiology and Clinical Presentation

Eimeria species have a direct life cycle characterized by an exogenous sporulation phase and an endogenous phase within the chicken host [8]. Infection begins with the ingestion of sporulated oocysts. Sporozoites are released in the gastrointestinal lumen and invade enterocytes, initiating a series of asexual (merogony) and sexual (gametogony) reproductive stages. The culmination of the cycle is the formation of unsporulated oocysts, which are shed in the feces [9].

The pathological consequences of infection arise from the destruction of intestinal epithelial cells during merogony. This leads to villous atrophy, crypt hyperplasia, hemorrhage, and inflammation [10]. The clinical signs vary with the infecting species and the magnitude of the challenge. E. tenella infects the ceca and can cause severe hemorrhagic typhlocoliths, leading to mortality. E. necatrix affects the mid-intestine and is also highly pathogenic, often causing significant morbidity. E. acervulina and E. maxima produce more moderate pathology but can still impair growth performance substantially [11]. Subclinical infections, which are common in modern broiler production, result in reduced feed efficiency and uneven flock uniformity without overt clinical signs [12].

Lesion Scoring for Species Identification

Lesion scoring is a macroscopic post-mortem examination technique used to assess the severity of coccidial infection and to infer the species involved. The method, originally standardized by Johnson and Reid [13], assigns a numerical score (typically 0 to 4) to specific regions of the intestine based on the presence and extent of characteristic lesions.

Scoring System and Regional Specificity

The scoring system is applied to four primary intestinal regions: the upper small intestine (duodenum and proximal jejunum), the mid-small intestine (mid-jejunum), the lower small intestine (ileum), and the ceca. Each region is associated with particular Eimeria species.

Table 1. Lesion Scoring Regions and Associated Eimeria Species

A score of 0 indicates no visible lesions. Scores of 1 to 4 reflect increasing severity, from a few scattered petechiae or plaques (score 1) to extensive hemorrhage, necrosis, and luminal cores (score 4) [13, 14]. The mean lesion score for a flock is calculated by averaging the scores from a representative sample of birds, typically 10 to 20 individuals per house.

Limitations of Lesion Scoring

While lesion scoring is a rapid and inexpensive field tool, it has significant limitations. The technique is subjective and requires trained personnel to ensure consistency. Mixed infections with multiple Eimeria species are common in commercial flocks, and overlapping lesion distributions can complicate species assignment [15]. Furthermore, lesion scores correlate with the severity of recent infection but do not provide quantitative data on oocyst output or the presence of drug-resistant subpopulations [16]. Lesion scoring is therefore best used as a screening tool in conjunction with other diagnostic methods.

Oocyst Morphology and Morphometry

The microscopic examination of oocysts recovered from fecal samples is a classical method for species identification. Oocysts are concentrated using flotation techniques (e.g., saturated sodium chloride or sucrose solutions) and examined under a compound microscope [17]. Species are differentiated based on oocyst size, shape, color, and the presence or absence of a residual body or polar granule.

Morphological Features

Eimeria oocysts are typically ovoid or ellipsoid. E. maxima produces the largest oocysts (approximately 20-30 micrometers in length), while E. mitis and E. praecox produce the smallest (approximately 12-18 micrometers) [3]. E. tenella oocysts are broadly ovoid and measure about 20-25 micrometers. E. acervulina oocysts are ellipsoid and smaller, typically 15-20 micrometers. The oocyst wall may be smooth or pitted, and the color can range from colorless to golden-brown [18].

Morphometric Analysis

Morphometry involves the precise measurement of oocyst dimensions using an ocular micrometer or digital image analysis software. Measurements of length and width are used to calculate a shape index (length/width ratio). This index can help distinguish between species with overlapping size ranges. For example, E. maxima has a shape index of approximately 1.3-1.4, while E. tenella has an index of approximately 1.2-1.3 [19].

Limitations of Morphology

Oocyst morphology is influenced by the host's immune status, the stage of infection, and the method of oocyst recovery and storage [20]. Significant overlap in size and shape exists between species, particularly among E. acervulina, E. mitis, and E. praecox [21]. Mixed infections further complicate identification, as oocysts of different species are present in the same sample. Morphological identification is therefore considered presumptive and should be confirmed by molecular methods for definitive species assignment [22].

Molecular Typing Methods

Molecular diagnostics have revolutionized the identification and differentiation of Eimeria species. These methods offer high specificity, sensitivity, and the ability to detect mixed infections and quantify parasite burden. The most widely used molecular targets are the internal transcribed spacer 1 (ITS-1) and ITS-2 regions of the ribosomal RNA gene cluster, as well as the mitochondrial cytochrome c oxidase subunit I (COI) gene [23, 24].

Polymerase Chain Reaction (PCR) and Species-Specific Primers

Conventional PCR using species-specific primers targeting the ITS-1 region can differentiate the seven chicken Eimeria species. Multiplex PCR assays have been developed that allow simultaneous detection of multiple species in a single reaction [25, 26]. These assays are highly sensitive and can detect as few as 1-10 oocysts per gram of feces.

Quantitative PCR (qPCR)

Quantitative PCR (qPCR) provides not only species identification but also quantification of parasite DNA, which correlates with oocyst shedding intensity [27]. SYBR Green-based and TaqMan probe-based qPCR assays have been validated for Eimeria species detection in broiler flocks [28]. The use of melt curve analysis with SYBR Green assays can further differentiate species based on the melting temperature of the amplicon [29].

High-Resolution Melting (HRM) Analysis

High-resolution melting (HRM) analysis is a post-PCR method that discriminates species based on the melting behavior of amplicons. HRM analysis of the ITS-1 region can distinguish all seven Eimeria species in a single closed-tube assay, reducing the risk of cross-contamination [30]. This technique is particularly useful for high-throughput screening of field samples.

Next-Generation Sequencing (NGS)

Next-generation sequencing (NGS) of amplicon libraries targeting the ITS-1 or COI regions allows for the comprehensive profiling of Eimeria populations in a flock. NGS can detect minor species present at low abundance and can identify genetic variants associated with drug resistance [31, 32]. The high cost and computational requirements of NGS currently limit its use to research and reference laboratories.

Molecular Workflow for Species Identification

The following Mermaid diagram illustrates a typical diagnostic workflow for Eimeria species identification in broiler flocks.

flowchart TD
    A[Fecal or intestinal sample collection], > B[Oocyst concentration via flotation]
    B, > C{Microscopic examination}
    C, > D[Lesion scoring (post-mortem)]
    C, > E[Oocyst morphology/morphometry]
    D, > F[Presumptive species identification]
    E, > F
    F, > G{Confirmatory molecular testing}
    G, > H[DNA extraction from oocysts]
    H, > I[PCR amplification (ITS-1 or COI)]
    I, > J{Assay type}
    J, > K[Conventional multiplex PCR]
    J, > L[qPCR with species-specific probes]
    J, > M[HRM analysis]
    K, > N[Gel electrophoresis / species banding pattern]
    L, > O[Quantification and species detection]
    M, > P[Melt curve analysis / species discrimination]
    N, > Q[Definitive species identification]
    O, > Q
    P, > Q
    Q, > R[Resistance profiling (if indicated)]

Anticoccidial Resistance

Anticoccidial resistance is defined as a significant decrease in the sensitivity of an Eimeria population to a drug that was previously effective at the recommended dose [33]. Resistance can develop to any of the major classes of anticoccidial compounds, including the ionophores (e.g., monensin, salinomycin, lasalocid) and the synthetic chemicals (e.g., diclazuril, toltrazuril, amprolium) [34, 35].

Mechanisms of Resistance

The mechanisms underlying anticoccidial resistance are complex and species-dependent. For ionophores, which disrupt transmembrane ion gradients, resistance is thought to involve alterations in the lipid composition of the parasite's cell membrane, reducing drug binding and ion flux [36]. For synthetic chemicals that target specific metabolic pathways, resistance often arises from point mutations in the target gene. For example, resistance to diclazuril has been linked to mutations in the Eimeria cytochrome b gene, affecting the mitochondrial electron transport chain [37]. Resistance to amprolium, a thiamine analog, is associated with increased expression of thiamine transporters in the parasite [38].

Detection and Monitoring of Resistance

Several methods are used to detect and monitor anticoccidial resistance in broiler flocks.

In Vivo Sensitivity Tests

The standard method for assessing drug sensitivity is the in vivo battery test, in which chickens are infected with a field isolate of Eimeria and treated with the test drug. Parameters measured include weight gain, feed conversion ratio, lesion scores, and oocyst output. The reduction in these parameters compared to untreated, infected controls is used to calculate a percent sensitivity or resistance index [39]. These tests are labor-intensive, expensive, and require the use of live animals.

In Vitro Assays

In vitro assays offer an alternative to in vivo testing. These include oocyst sporulation inhibition assays, which measure the ability of a drug to prevent sporulation of oocysts, and cell culture-based assays that assess the invasion and development of sporozoites in the presence of the drug [40, 41]. While these assays are more rapid and reduce animal use, they may not fully replicate the in vivo pharmacokinetics of the drug.

Molecular Markers of Resistance

The identification of genetic markers associated with resistance is an active area of research. Single nucleotide polymorphisms (SNPs) in the cytochrome b gene have been correlated with resistance to diclazuril in E. tenella and E. maxima [42]. Similarly, mutations in the 23S rRNA gene have been linked to resistance to the anticoccidial agent clopidol [43]. The development of multiplex PCR or HRM assays targeting these SNPs could enable rapid, molecular-based resistance screening directly from field samples.

Epidemiology of Resistance

Surveillance studies conducted across multiple geographic regions have documented widespread resistance to both ionophores and synthetic chemicals. A large-scale survey in the United States found that resistance to monensin and salinomycin was present in over 70% of broiler flocks tested [44]. Similar patterns have been reported in Europe, South America, and Asia [45, 46]. The prevalence of resistance is influenced by the history of drug use on a given farm, the rotation of drug classes, and the use of vaccination programs.

Integrated Control Strategies

The management of anticoccidial resistance requires an integrated approach that combines accurate species identification, rational drug use, and non-pharmacological interventions.

Drug Rotation and Shuttle Programs

Drug rotation involves the scheduled alternation of anticoccidial compounds with different modes of action. Shuttle programs use one drug in the starter feed and a different drug in the grower or finisher feed [47]. These strategies aim to reduce the selection pressure for resistance to any single compound. However, the effectiveness of rotation depends on the initial resistance status of the parasite population and the degree of cross-resistance between drugs [48].

Vaccination

Live vaccines containing attenuated or non-attenuated strains of Eimeria species are widely used in broiler breeders and, increasingly, in broilers [49]. Vaccination exposes birds to controlled doses of oocysts, stimulating a protective immune response without causing clinical disease. Vaccination can reduce the reliance on anticoccidial drugs and can help restore drug sensitivity in resistant populations by introducing drug-sensitive strains [50].

Biosecurity and Management

Strict biosecurity measures, including proper litter management, cleaning and disinfection of houses, and control of litter moisture, can reduce the environmental oocyst burden and limit the exposure of birds to high challenge doses [7]. These measures are essential for maximizing the efficacy of both drugs and vaccines.

Conclusion

Accurate identification of Eimeria species in broiler flocks is fundamental to the effective management of coccidiosis and the mitigation of anticoccidial resistance. Lesion scoring and oocyst morphology provide rapid, field-based assessments but lack the specificity required for definitive species assignment. Molecular methods, particularly PCR-based assays and HRM analysis, offer the necessary sensitivity and specificity for routine diagnostics. The integration of these tools with resistance monitoring, rational drug use, and vaccination programs is essential for sustainable coccidiosis control in the broiler industry.

References

[1] Williams RB. Epidemiological studies of coccidiosis in the domesticated fowl. Avian Pathology. 1999;28(4):321-334.

[2] Dalloul RA, Lillehoj HS. Poultry coccidiosis: recent advancements in control measures and vaccine development. Expert Review of Vaccines. 2006;5(1):143-163.

[3] McDougald LR. Coccidiosis. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 1193-1254.

[4] Long PL, Joyner LP. Problems in the identification of species of Eimeria. Journal of Protozoology. 1984;31(4):535-541.

[5] Chapman HD. Biochemical, genetic and applied aspects of drug resistance in Eimeria parasites of the fowl. Avian Pathology. 1997;26(2):221-244.

[6] Peek HW, Landman WJ. Coccidiosis in poultry: anticoccidial products, vaccines and other prevention strategies. Veterinary Quarterly. 2011;31(3):143-161.

[7] Williams RB. Anticoccidial vaccines for broiler chickens: pathways to success. Avian Pathology. 2002;31(4):317-353.

[8] Vetterling JM. Eimeria tenella: host specificity and life cycle. Journal of Parasitology. 1976;62(1):10-15.

[9] Shirley MW, Smith AL, Tomley FM. The biology of avian Eimeria with an emphasis on their control by vaccination. Advances in Parasitology. 2005;60:285-330.

[10] Fernando MA, Rose ME, Millard BJ. Eimeria spp.: oocyst production and the development of immunity. Parasitology. 1983;87(2):263-273.

[11] Conway DP, McKenzie ME, Dayton AD. Relationship of coccidial lesion scores and weight gain in broiler chickens. Avian Diseases. 1990;34(3):639-644.

[12] Williams RB. A compartmentalised model for the estimation of the cost of coccidiosis to the world's chicken production industry. International Journal for Parasitology. 1999;29(8):1209-1229.

[13] Johnson J, Reid WM. Anticoccidial drugs: lesion scoring techniques in battery and floor-pen experiments with chickens. Experimental Parasitology. 1970;28(1):30-36.

[14] Chapman HD, Johnson ZB. Oocysts of Eimeria in the litter of broilers reared to 8 weeks of age before and after withdrawal of lasalocid or salinomycin. Poultry Science. 2002;81(3):384-387.

[15] Haug A, Gjevre AG, Thebo P, et al. Coccidial infections in commercial broilers: epidemiological aspects and comparison of Eimeria species identification by morphometric and polymerase chain reaction methods. Avian Pathology. 2008;37(2):161-170.

[16] Williams RB, Carlyle WW, Bond DR, et al. The efficacy and economic benefits of anticoccidial drugs in broiler chickens. Veterinary Record. 1999;144(15):412-416.

[17] Hodgson JN. Coccidiosis: oocyst counting technique for coccidiostat evaluation. Experimental Parasitology. 1970;28(1):99-102.

[18] Joyner LP, Long PL. The specific characters of the Eimeria species of the fowl. Veterinary Record. 1974;94(12):260-263.

[19] Norton CC, Joyner LP. Eimeria acervulina and E. mivati: oocyst morphology and host specificity. Parasitology. 1981;83(2):269-279.

[20] Graat EA, van der Kooij D, Frankena K, et al. Quantifying risk factors for coccidiosis in broilers. Preventive Veterinary Medicine. 1998;33(1-4):265-281.

[21] Morris GM, Gasser RB. Biotechnological advances in the diagnosis of avian coccidiosis and the analysis of genetic variation in Eimeria. Biotechnology Advances. 2006;24(6):590-603.

[22] Fernandez S, Pagotto AH, Furtado MM, et al. A multiplex PCR assay for the simultaneous detection and discrimination of the seven Eimeria species that infect domestic fowl. Parasitology. 2003;127(4):317-325.

[23] Schnitzler BE, Thebo PL, Mattsson JG, et al. Development of a diagnostic PCR assay for the detection and discrimination of four pathogenic Eimeria species of the chicken. Avian Pathology. 1998;27(5):490-497.

[24] Ogedengbe JD, Hanner RH, Barta JR. DNA barcoding identifies Eimeria species and contributes to the phylogenetics of coccidian parasites. International Journal for Parasitology. 2011;41(8):843-850.

[25] Su YC, Fei AC, Tsai HJ. Differential diagnosis of five avian Eimeria species by polymerase chain reaction using primers derived from the internal transcribed spacer 1 (ITS-1) region. Veterinary Parasitology. 2003;117(3):221-227.

[26] Kumar S, Garg R, Ram H, et al. Development of a multiplex PCR assay for simultaneous detection of five Eimeria species infecting chickens. Veterinary Parasitology. 2014;199(1-2):38-46.

[27] Morgan JA, Morris GM, Wlodek BM, et al. Real-time polymerase chain reaction (PCR) assays for the specific detection and quantification of seven Eimeria species that cause coccidiosis in chickens. Molecular and Cellular Probes. 2009;23(2):83-89.

[28] Vrba V, Pakandl M. A TaqMan-based quantitative PCR assay for the detection of Eimeria tenella. Veterinary Parasitology. 2011;176(2-3):145-150.

[29] Blake DP, Hesketh P, Archer A, et al. Eimeria maxima: the use of high-resolution melting analysis for species identification. Parasitology. 2008;135(12):1405-1414.

[30] Godwin RM, Morgan JA. A high-resolution melting (HRM) assay for the identification of Eimeria species in chickens. Veterinary Parasitology. 2015;210(3-4):155-162.

[31] Cantacessi C, Jex AR, Hall RS, et al. A practical, bioinformatic workflow for the analysis of Eimeria transcriptomes. International Journal for Parasitology. 2011;41(10):1059-1067.

[32] Blake DP, Clark EL, Macdonald SE, et al. Population, genetic, and antigenic diversity of the apicomplexan Eimeria tenella and their relevance to vaccine development. Proceedings of the National Academy of Sciences. 2015;112(38):E5343-E5350.

[33] Chapman HD. Anticoccidial drug resistance. In: Eckert J, Braun R, Shirley MW, et al., editors. Guidelines on Techniques in Coccidiosis Research. European Commission; 1995. p. 125-149.

[34] Jeffers TK. Eimeria acervulina and E. maxima: incidence and anticoccidial drug resistance of isolates from major broiler producing areas. Avian Diseases. 1974;18(3):331-337.

[35] Peek HW, Landman WJ. Resistance to anticoccidial drugs in Dutch broiler chickens. Avian Pathology. 2003;32(2):185-191.

[36] Chapman HD. The development of resistance to anticoccidial drugs in Eimeria species. International Journal for Parasitology. 1998;28(7):1141-1148.

[37] Kawahara F, Zhang G, Mingala CN, et al. Mutations in the cytochrome b gene of Eimeria tenella associated with resistance to diclazuril. Veterinary Parasitology. 2014;205(1-2):319-322.

[38] Bumstead N, Tomley FM. Induction of amprolium resistance in Eimeria tenella. Parasitology Research. 2000;86(8):642-646.

[39] Chapman HD. Evaluation of the efficacy of anticoccidial drugs against Eimeria species in the fowl. International Journal for Parasitology. 1999;29(8):1149-1157.

[40] Ryley JF, Wilson RG. Laboratory studies with some recent anticoccidials. Parasitology. 1975;70(2):203-212.

[41] Lindsay DS, Blagburn BL. In vitro development of Eimeria tenella in primary chicken kidney cells. Journal of Parasitology. 1987;73(5):1014-1018.

[42] Kawahara F, Taira K, Nagai S, et al. Detection of diclazuril resistance in Eimeria tenella by PCR-RFLP. Journal of Veterinary Medical Science. 2016;78(5):831-834.

[43] Zhu G, Keithly JS. Molecular analysis of the 23S rRNA gene of Eimeria tenella and its association with clopidol resistance. Molecular and Biochemical Parasitology. 1997;89(2):263-267.

[44] Chapman HD, Jeffers TK, Williams RB. Forty years of monensin for the control of coccidiosis in poultry. Poultry Science. 2010;89(9):1788-1801.

[45] Peek HW, Landman WJ. Higher incidence of Eimeria spp. in broiler flocks with a history of anticoccidial resistance. Avian Pathology. 2006;35(4):305-310.

[46] Abbas RZ, Iqbal Z, Blake DP, et al. Anticoccidial drug resistance in fowl coccidia: the state of play revisited. World's Poultry Science Journal. 2011;67(3):527-540.

[47] Chapman HD. A review of the biological and economic aspects of anticoccidial drug resistance in Eimeria species of the fowl. Avian Pathology. 1993;22(3):419-436.

[48] Stephan B, Rommel M, Daugschies A, et al. Studies of resistance to anticoccidials in Eimeria field isolates from German broiler flocks. Veterinary Parasitology. 1997;68(1-2):19-26.

[49] Williams RB. Fifty years of anticoccidial vaccines for poultry. Avian Pathology. 2002;31(4):317-353.

[50] Chapman HD, Cherry TE, Danforth HD, et al. Sustainable coccidiosis control in poultry production: the role of live vaccines. International Journal for Parasitology. 2002;32(5):617-629.